Maia M
Making MALDI-TOF MS for entomological parameters accessible: A practical guide for in-house library creation.Karisa J, Tuwei M, Ominde K, Bartilol B, Ondieki Z, Musani H, Rono M, Mbogo C, Bejon P, Mwangangi J, Wanjiku C, Maia M
PLoS One, (2025). 20:e0330605
Spatial distribution and population structure of the invasive Anopheles stephensi in Kenya from 2022 to 2024.Samake JN, Athinya DK, Milanoi S, Ramaita E, Muchoki M, Omondi S, Abong'o B, Matoke-Muhia D, Mbogo C, Keitany K, Mukabana WR, Oyieke F, Shieshia M, Mburu M, Ogoma S, Nyawira E, Wekesa C, Bartilol B, Rono M, Maia M, O'Meara W, Kahindi S, Rafferty C, Schultz JS, Gutman JR, Gimnig JE, Zohdy S, Ochomo E
Sci Rep, (2025). 15:19878
Age structure and parity status determination of Afrotropical malaria vectors using MALDI-TOF MS.Tuwei M, Karisa J, Kiuru C, Ondieki Z, Odongo T, Muturi M, Mure F, Otieno B, Okoko M, Bartilol B, Gona R, Ominde K, Constantino L, Cole G, Anastácio T, Candrinho B, Armazia R, Alves C, Ramaita E, Rono M, Mwangangi J, Mbogo C, Saute F, Chaccour C, Wanjiku C, Maia M
Sci Rep, (2025). 15:15848
Age structure and parity status determination of Afrotropical malaria vectors using MALDI-TOF MS.Tuwei M, Karisa J, Kiuru C, Ondieki Z, Odongo T, Muturi M, Mure F, Otieno B, Okoko M, Bartilol B, Gona R, Ominde K, Constantino L, Cole G, Anastácio T, Candrinho B, Armazia R, Alves C, Ramaita E, Rono M, Mwangangi J, Mbogo C, Saute F, Chaccour C, Wanjiku C, Maia M
Sci Rep, (2025). 15:15848
Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya.Onyango T, Nuru K, Kazungu K, Wangari W, Chaccour C, Regina Rabinovich N, Mwangangi J, Maia M, Jones C
Malar J, (2025). 24:79
Ivermectin to Control Malaria — A Cluster-Randomized Trial.Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P, Wanjiku C, Kasiwa L, Brazeal A, Casellas A, Ngama M, Onyango T, Elobolobo E, Kazungu K, Mael M, Wangari W, Nuru K, Otuko R, Sanz A, Ringera I, Matano A, Mitora S, Ribes M, Brew J, Gorski N, Nicolas P, Stanulovic S, Omondi I, Furnival-Adams J, Túnez L, Mbarak J, Vegove V, Yaa E, Mramba S, Kibet Y, Nyambura N, Rotich C, Wanjiru S, Vura M, Wanjiku F, Sam L, Collins L, Xia K, Hammann F, Saúte F, Rudd M, Rist C, Jones C, Mwangangi J, Rabinovich NR
New England Journal of Medicine, (2025). 393:362-375
Molecular xenomonitoring reveals Anopheles funestus and An.�rivulorum as the primary vectors of lymphatic filariasis in coastal Kenya.Bartilol B, Babu L, Garama K, Karisa J, Kamau A, Mwandawiro C, Wanjiku C, Mbogo C, Maia M, Mwangangi J, Rono MK
Parasit Vectors, (2024). 17:425
Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life.Elson L, Kamau C, Koech S, Muthama C, Gachomba G, Sinoti E, Chondo E, Mburu E, Wakio M, Lore J, Maia M, Adetifa I, Orindi B, Bejon P, Fillinger U
PLoS Negl Trop Dis, (2024). 18:e0011800
Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast.Karisa J, Ominde K, Tuwei M, Bartilol B, Ondieki Z, Musani H, Wanjiku C, Mwikali K, Babu L, Rono M, Eminov M, Mbogo C, Bejon P, Mwangangi J, Laroche M, Maia M
Wellcome Open Res, (2023). 8:151
Detection of Anopheles stephensi Mosquitoes by Molecular Surveillance, Kenya.Ochomo EO, Milanoi S, Abong'o B, Onyango B, Muchoki M, Omoke D, Olanga E, Njoroge L, Juma EO, Otieno JD, Matoke-Muhia D, Kamau L, Rafferty C, Gimnig JE, Shieshia M, Wacira D, Mwangangi J, Maia M, Chege C, Omar A, Rono MK, Abel L, O'Meara WP, Obala A, Mbogo C, Kariuki L
Emerg Infect Dis, (2023). 29:2498-2508
National prevalence and risk factors for tungiasis in Kenya.Elson L, Kamau C, Koech S, Muthama C, Gachomba G, Sinoti E, Chondo E, Mburu E, Wakio M, Lore J, Maia M, Adetifa I, Orindi B, Bejon P, Fillinger U
Infect Dis Poverty, (2023). 12:85
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.Chaccour C, Casellas A, Hammann F, Ruiz-Castillo P, Nicolas P, Monta�a J, Mael M, Selvaraj P, Duthaler U, Mrema S, Kakolwa M, Lyimo I, Okumu F, Marathe A, Sch�rch R, Elobolobo E, Sacoor C, Saute F, Xia K, Jones C, Rist C, Maia M, Rabinovich NR
Trials, (2023). 24:128
Vectorial capacity and TEP1 genotypes of Anopheles gambiae sensu lato mosquitoes on the Kenyan coast.Bartilol B, Omuoyo D, Karisa J, Ominde K, Mbogo C, Mwangangi J, Maia M, Rono MK
Parasit Vectors, (2022). 15:448
Malaria vector bionomics in Taita-Taveta County, coastal Kenya.Karisa J, Ominde K, Muriu S, Munyao V, Mwikali K, Babu L, Ondieki Z, Bartilol B, Tuwei M, Wanjiku C, Maia M, Midega J, Rono M, Peshu N, Mbogo C, Mwangangi JM
Parasit Vectors, (2022). 15:430
Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study.Nicolas P, Kiuru C, Wagah MG, Muturi M, Duthaler U, Hammann F, Maia M, Chaccour C
Parasit Vectors, (2021). 14:172
Effectiveness of Rotarix ((R)) vaccine in Africa in the first decade of progressive introduction, 2009-2019: systematic review and meta-analysis.Murunga N, Otieno PG, Maia M, Agoti CN
Wellcome Open Res, (2020). 5:187
Can trials of spatial repellents be used to estimate mosquito movement?.Malinga J, Maia M, Moore S, Ross A
Parasit Vectors, (2019). 12:421
Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.Chaccour CJ, Hammann F, Alustiza M, Castejon S, Tarimo BB, Abizanda G, Irigoyen Barrio A, Marti Soler H, Moncada R, Bilbao JI, Aldaz A, Maia M, Del Pozo JL
Sci Rep, (2017). 7:8535
